Maravai LifeSciences Holdings, Inc. (MRVI)
Automate Your Wheel Strategy on MRVI
With Tiblio's Option Bot, you can configure your own wheel strategy including MRVI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MRVI
- Rev/Share 1.6863
- Book/Share 3.6972
- PB 1.0353
- Debt/Equity 0.1236
- CurrentRatio 5.9578
- ROIC -0.2925
- MktCap 312425750.0
- FreeCF/Share -0.1617
- PFCF -13.4748
- PE -1.9128
- Debt/Assets 0.0387
- DivYield 0
- ROE -0.4623
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | MRVI | Robert W. Baird | Outperform | Neutral | $9 | $3 | Feb. 26, 2025 |
| Initiation | MRVI | Guggenheim | -- | Neutral | -- | -- | Dec. 19, 2024 |
| Downgrade | MRVI | Goldman | Neutral | Sell | -- | $4.25 | Dec. 5, 2024 |
| Initiation | MRVI | Wells Fargo | -- | Overweight | -- | $10 | Aug. 28, 2024 |
News
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MRVI
Published: April 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit.
Read More
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Published: April 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=146005&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Lawsuit - MRVI
Published: April 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145990&wire=1 or contact Joseph E. Levi, Esq.
Read More
Shareholders that lost money on Maravai LifeSciences Holdings, Inc.(MRVI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Published: April 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145962&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Published: April 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145935&wire=1 or contact Joseph E. Levi, Esq.
Read More
Contact Levi & Korsinsky by May 5, 2025 Deadline to Join Class Action Against Maravai LifeSciences Holdings, Inc. (MRVI)
Published: April 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145903&wire=1 or contact Joseph E. Levi, Esq.
Read More
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman
Published: April 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
MRVI Investors with Losses Encouraged to Contact the Firm Before May 5th Deadline MRVI Investors with Losses Encouraged to Contact the Firm Before May 5th Deadline
Read More
Maravai LifeSciences Holdings, Inc. Class Action: Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Published: April 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145818&wire=1 or contact Joseph E. Levi, Esq.
Read More
May 5, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRVI
Published: April 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI).
Read More
Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact The Gross Law Firm about pending Class Action - MRVI
Published: April 28, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read More
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: April 28, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , April 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 7, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2025.
Read More
MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – MRVI
Published: April 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline.
Read More
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Published: April 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
Read More
Lost Money on Maravai LifeSciences Holdings, Inc. (MRVI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Published: April 25, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 25, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145143&wire=1 or contact Joseph E. Levi, Esq.
Read More
MRVI Investors Have the Opportunity to Lead the Maravai LifeSciences Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Published: April 25, 2025 by: Accesswire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / April 25, 2025 / If you suffered losses exceeding $50,000 in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential …
Read More
MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Published: April 25, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. So what: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
Maravai LifeSciences Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Published: April 25, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 25, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145137&wire=1 or contact Joseph E. Levi, Esq.
Read More
Lost Money on Maravai LifeSciences Holdings, Inc. (MRVI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Published: April 25, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 25, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145134&wire=1 or contact Joseph E. Levi, Esq.
Read More
Lowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
Published: April 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).
Read More
May 5, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRVI
Published: April 25, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 25, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=145111&wire=1 or contact Joseph E. Levi, Esq.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
Published: April 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
Maravai LifeSciences Holdings, Inc. Class Action: Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Published: April 24, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=144940&wire=1 or contact Joseph E. Levi, Esq.
Read More
Deadline Approaching: Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Published: April 24, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , April 24, 2025 /PRNewswire/ -- Law Offices of Howard G.
Read More
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRVI
Published: April 23, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=144757&wire=1 or contact Joseph E. Levi, Esq.
Read More
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - MRVI
Published: April 23, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 23, 2025 / WHY: New York, N.Y., April 23, 2025.
Read More
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights – MRVI
Published: April 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI).
Read More
Maravai LifeSciences Holdings, Inc. Class Action: Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Published: April 23, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=144730&wire=1 or contact Joseph E. Levi, Esq.
Read More
MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Published: April 22, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 22, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=144476&wire=1 or contact Joseph E. Levi, Esq.
Read More
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
Published: April 22, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period").
Read More
Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Published: April 22, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Maravai LifeSciences investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 24, 2025.
Read More
About Maravai LifeSciences Holdings, Inc. (MRVI)
- IPO Date 2020-11-20
- Website https://www.maravai.com
- Industry Biotechnology
- CEO Mr. William E. Martin III
- Employees 570